News Coverage

Read what people are saying about us.

April 29, 2022

OneSource Announced as a Grand Prize Winner in the 2022 Bio-IT World Innovative Practices Awards

April 11, 2022

Natera to Present Data from BEATRICE & I-SPY2 Trials in Early-Stage TNBC & HR+/HER2- Breast Cancer

April 5, 2022

UCSF, QLHC & FDA Announce Deployment of Innovative Data Capture System for Clinical Care & Research

May 18, 2021

ACS CAN & CodeX Lead Project to Expand Cancer Clinical Trial Enrollment Through Improved Technology

April 27, 2021

Laura Esserman in conversation with Janet Woodcock, Acting Commissioner of the FDA, at CRAACO 2021

June 8, 2020

Quantum leap selects Sanofi's SAR439859 as the Oral SERD in the Endocrine Optimization Pilot

November 21, 2019

This Doctor Wants to Use Salesforce Blockchain to Cut Cancer Drug Development Costs in Half

March 27, 2019

Podcast: Dr Laura Esserman discusses the integration of clinical care and clinical research

February 15, 2019

Esserman among bioscience leaders profiled in SF Business Times

January 23, 2019

Laura Esserman argues for renaming low-risk cancer in the BMJ

October 4, 2018

Dr. Laura Esserman featured on Second Opinion: Precision Medicine in Breast Cancer Treatment

September 12, 2018

I-SPY 2 TRIAL featured on CBS NY's Health Watch: Testing Breast Cancer Drugs To Avoid Surgery

September 12, 2018

Woodcock Hopes I-SPY 2 Trial Is 'Blazing The Trail' For Future Adaptive Design Uptake (Paid)

August 29, 2018

Study: Breast cancer surgery could be more dangerous for nursing home patients than cancer

May 31, 2018

Dr. Laura Esserman recognized as a 2018 Fellow of the American Society of Clinical Oncology (FASCO)

May 22, 2018

Should Tech Entrepreneurs Aspire To Fix Clinical Trials Or Reinvent Them?

May 20, 2018

SF Business Times names Dr. Esserman as one of the most influential women in Bay Area business 2018

April 18, 2018

Dr. Laura Esserman named as one of the 20 Most Influential Moms of 2018

April 1, 2018

Researchers Double Effort to Enroll Women in Breast-Disease Study

July 12, 2017

Help design sensible, effective breast cancer screening guidelines

July 10, 2017

The Wisdom Study Takes A New Look At Breast Cancer Screenings

July 10, 2017

MammaPrint Identifies Breast Cancer Patients Who Can Skip Chemotherapy

March 10, 2016

New tool pairs women with breast cancer trials

November 3, 2015

The debate over early breast cancer treatment

October 21, 2015

How to Untangle Conflicting Mammogram Advice

October 13, 2015

Is It Possible to Have Too Much Info About Breast Cancer?

September 29, 2015

Why this surgeon challenges overuse of cancer screenings, but spends hours with patients

September 23, 2015

Podcast: DCIS dilemma with Dr. Laura Esserman

August 20, 2015

Reduced invasive recurrence after DCIS does not reduce mortality

This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.